Episode Details

Health systems are eager to adopt AI for aging populations, but does the technology actually save money? We unpack a scoping review of 40 economic evaluations to reveal why most AI tools are deemed cost-saving on paper, but often lack the real-world validation to prove it.

Key points

• Of 40 economic evaluations, 21 reported AI interventions to be cost-saving and 17 reported them to be cost-effective.
• Despite high methodological scores, model validation was not reported in 21 of the 40 included studies.
• Evidence is heavily skewed toward screening and diagnosis (32 out of 40 studies), with very few evaluating long-term monitoring or personalized care.
• AI-related costs were frequently derived from assumptions, expert opinion, or manufacturer quotes rather than real-world trial data.
• Key drivers of cost-effectiveness included algorithm performance, AI-related costs, underlying disease epidemiology, and local contextual factors like labor costs.

Source: Assessing the Value for Money of AI-Assisted Technologies for Older Adults: Scoping Review of Economic Evaluations - Journal of medical Internet research, 2026 (CC BY)

This spot is available. Reach clinicians, health-system leaders and medtech and pharma teams following AI in medicine. Sponsor the show

This episode is an AI-generated conversation summarising a public document; the hosts' voices are synthetic. It is for information only and is not medical advice. Always refer to the original source.

Full transcript: https://ai-in-medicine-podcast.vercel.app/episodes/does-ai-in-eldercare-actually-save-money-a-hard-look-at-the-health-eco-84c385